1-11 of 11 Search Results for

Medicare

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
DOI: 10.1215/9780822375500-005
EISBN: 978-0-8223-7550-0
... This chapter turns to the Medicare insurance system, whose reimbursement policies and decisions convert best evidence into available treatments—the second transformation in the chain of health care drivers. Medicare reimbursement decisions organize the next two transformations in the chain...
Published: 01 February 2006
DOI: 10.1215/9780822387633-002
EISBN: 978-0-8223-8763-3
Published: 08 August 2005
DOI: 10.1215/9780822387343-004
EISBN: 978-0-8223-8734-3
Published: 08 August 2005
DOI: 10.1215/9780822387343-007
EISBN: 978-0-8223-8734-3
Published: 08 August 2005
DOI: 10.1215/9780822387343-008
EISBN: 978-0-8223-8734-3
Book Chapter

By Sharon R. Kaufman
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
EISBN: 978-0-8223-7550-0
... Medicare treatment standards Big Pharma medical cost reimbursement ...
Book Chapter

By Sharon R. Kaufman
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
EISBN: 978-0-8223-7550-0
... medical technologies implantable cardiac defibrillator kidney dialysis liver transplantation Medicare eligibility ...
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
EISBN: 978-0-8223-7550-0
... that the pharmaceutical and biotech industries and the for-profit market for technologies have a growing impact on shaping research agendas and thus on shaping treatments. Medicare treatment standards Big Pharma medical cost reimbursement This chapter turns to the Medicare insurance system, whose...
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
DOI: 10.1215/9780822375500-004
EISBN: 978-0-8223-7550-0
...: the fact that the pharmaceutical and biotech industries and the for-profit market for technologies have a growing impact on shaping research agendas and thus on shaping treatments. Medicare treatment standards Big Pharma medical cost reimbursement ...
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
DOI: 10.1215/9780822375500-006
EISBN: 978-0-8223-7550-0
... the quandary of determining how one should live in relation to the tools of medicine as one grows old. medical technologies implantable cardiac defibrillator kidney dialysis liver transplantation Medicare eligibility ...
Series: Critical Global Health: Evidence, Efficacy, Ethnography
Published: 04 May 2015
EISBN: 978-0-8223-7550-0
... large here, and each patient’s story illustrates the quandary of determining how one should live in relation to the tools of medicine as one grows old. medical technologies implantable cardiac defibrillator kidney dialysis liver transplantation Medicare eligibility This chapter...